Differential expression of sirtuins in the aging rat brain

Frontiers in Cellular Neuroscience

Volumn 9, Issue MAY, 2015, Pages

  Braidy, Nady ^a   Poljak, Anne ^b   Grant, Ross ^b,c   Jayasena, Tharusha ^a   Mansour, Hussein ^d   Chan Ling, Tailoi ^d   Smythe, George ^b   Sachdev, Perminder ^a,e   Guillemin, Gilles J ^f  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c SYDNEY ADVENTIST HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e PRINCE OF WALES HOSPITAL   (Australia)

^f MACQUARIE UNIVERSITY   (Australia)

Author keywords

Aging; Brain; Longevity; P53; Sirtuins

Indexed keywords

CARBAMOYL PHOSPHATE SYNTHASE; DNA DIRECTED RNA POLYMERASE; HISTONE H3; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; POL PROTEIN; PROTEIN P53; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; SIRTUIN 4; SIRTUIN 5; SIRTUIN 6; SIRTUIN 7; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR FKHRL1;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; FATTY ACID OXIDATION; FEMALE; FRONTAL LOBE; GENE EXPRESSION; HIPPOCAMPUS; HISTONE ACETYLATION; NONHUMAN; OCCIPITAL LOBE; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84929583381     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00167     Document Type: Article

References (88)

1. Ahn, B., Kim, H., Song, S., Lee, I., Liu, J., Vassilopoulos, A., et al. (2008). A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc. Natl. Acad. Sci. U.S.A. 105, 14447-14452. doi: 10.1073/pnas.0803790105
2. Alafuzoff, I., Iqbal, K., Friden, H., Adolfsson, R., and Winblad, B. (1987). Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis. Acta Neuropathol. (Berl) 74, 209-225. doi: 10.1007/BF00688184
3. Anastasiou, D., and Krek, W. (2006). SIRT1: linking adaptive cellular responses to aging-associated changes in organismal physiology. Physiology (Bethesda) 21, 404-410. doi: 10.1152/physiol.00031.2006
4. Andersen, J. (2004). Oxidative stress in neurodegeneration: cause or consequence? Nat. Med. 10(Suppl.), S18-S25. doi: 10.1038/nrn1434
5. Anekonda, T. S., and Reddy, P. H. (2006). Neuronal protection by sirtuins in Alzheimer’s disease. J. Neurochem. 96, 305-313. doi: 10.1111/j.1471-4159.2005.03492.x
6. Arraki, T., Sasaki, A., and Milbrandt, J. (2004). Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305, 1010-1013. doi: 10.1126/science.1098014
7. Beal, M. F. (1995). Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38, 357-366. doi: 10.1002/ana.410380304
8. Beal, M. F. (2003). Mitochondria, oxidative damage, and inflammation in Parkinson’s disease. Ann. N.Y. Acad. Sci. 991, 120-131. doi: 10.1111/j.1749-6632.2003.tb07470.x
9. Beal, M. F. (2007). Mitochondria and neurodegeneration. Novartis Found Symp. 287, 183-192. discussion: 192-186. doi: 10.1002/SERIES1767
10. Belenky, P., Bogan, K. L., and Brenner, C. (2007). NAD+ metabolism in health and disease. Trends Biochem. Sci. 32, 12-19. doi: 10.1016/j.tibs.2006.11.006
11. Berdichevsky, A., and Guarente, L. (2006). A stress response pathway involving sirtuins, forkheads and 14-3-3 proteins. Cell Cycle 5, 2588-2591. doi:10.4161/cc.5.22.3513
12. Borra, M. T., Smith, B. C., and Denu, J. M. (2005). Mechanism of human SIRT1 activation by resveratrol. J. Biol. Chem. 280, 17187-17195. doi:10.1074/jbc.M501250200
13. Bradford, M. M. (1976). A rapid and sensitive method for quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal. Biochem. 53, 452-458.
14. Braidy, N., Guillemin, G. M. H., Chan-Ling, T., Poljak, A., and Grant, R. (2011). Age related changes in NAD+ metabolism, oxidative stress and Sirt1 Activity in Wistar Rats. PLoS ONE 6:e19194. doi: 10.1371/journal.pone.0019194
15. Brown, K., Chu, Y., Lund, D., Heistad, D., and Faraci, F. (2006). Gene transfer of extracellular superoxide dismutase protects against vascular dysfunction with aging. Am. J. Physiol. Heart Circ. Physiol. 290, H2600-H2605. doi: 10.1152/ajpheart.00676.2005
16. Brunet, A., Sweeny, L. B., and Sturgill, J. F. (2004). Stress-dependent regulation of FOXO transcription factors by SIRT1 deacetylase. Science 303, 2011-2015. doi: 10.1126/science.1094637
17. Budd, S. L., and Nicholls, D. G. (1996). Mitochondria, calcium regulation, and acute glutramate excitotoxicity in cultured cerebellar granule cells. J. Neurochem. 67, 2282-2291. doi: 10.1046/j.1471-4159.1996.67062282.x
18. Budd, S. L., Tenneti, L., Lishnak, T., and Lipton, S. A. (2000). Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons. Proc. Natl. Acad. Sci. U.S.A. 97, 6161-6166. doi: 10.1073/pnas.100121097
19. Chan-Ling, T. (1997). Glial, vascular, and neuronal cytogenesis in whole-mounted cat retina. Microsc. Res. Tech. 36, 1-16.
20. Chen, D., and Guarente, L. (2007). SIR2: a potential target for calorie restriction mimetics. Trends Mol. Med. 13, 64-71. doi: 10.1016/j.molmed.2006.12.004
21. Chen, J., Zhou, Y., Mueller-Steiner, S., Chen, L. F., Kwon, H., Yi, S., et al. (2005). SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J. Biol. Chem. 280, 40364-40374. doi: 10.1074/jbc.M509329200
22. Choudhuri, S., Cherrington, N. J., Li, N., and Klaassen, C. D. (2003). Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats. Drug Metab. Dispos. 31, 1337-1345. doi: 10.1124/dmd.31.11.1337
23. Coleman, P. (1989). How old is old? Neurobiol. Aging 10, 115
24. Collier, T. J., and Coleman, P. D. (1991). Divergence of biological and chronological aging: evidence from rodent studies. Neurobiol. Aging 12, 685-693. doi: 10.1016/0197-4580(91)90122-Z
25. Conti, V., Corbi, G., Simeon, V., Russomanno, G., Manzo, V., Ferrara, N., et al. (2015). Aging-related changes in oxidative stress response of human endothelial cells. Aging Clin. Exp. Res. doi: 10.1007/s40520-015-0357-9. [Epub ahead of print].
26. Dali-Youcef, N., Lagouge, M., Froelich, S., Koehl, C., Schoonjans, K., and Auwerx, J. (2007). Sirtuins: the ‘magnificent seven’, function, metabolism and longevity. Ann. Med. 39, 335-345. doi: 10.1080/07853890701408194
27. Denu, J. M. (2005). The Sir 2 family of protein deacetylases. Curr. Opin. Chem. Biol. 9, 431-440. doi: 10.1016/j.cbpa.2005.08.010
28. Denu, J. M. (2007). Vitamins and aging: pathways to NAD+ synthesis. Cell 129, 453-454. doi: 10.1016/j.cell.2007.04.023
29. Dryden, S., Nahhas, F., Nowak, J., Goustin, A., and Tainsky, M. (2003). Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle. Mol. Cell. Biol. 23, 3173-3185. doi: 10.1128/MCB.23.9.3173-3185.2003
30. Ferrara, N., Rinaldi, B., Corbi, G., Conti, V., Stiuso, P., Boccuti, S., et al. (2008). Exercise training promotes SIRT1 activity in aged rats. Rejuvenation Res. 11, 139-150. doi: 10.1089/rej.2007.0576
31. Ford, E., Voit, R., Liszt, G., Magin, C., Grummt, I., and Guarente, L. (2006). Mammalian Sirt2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev. 20, 1075-1080. doi: 10.1101/gad.1399706
32. Ford, J., Jiang, M., and Milner, J. (2005). Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival. Canc. Res. 65, 10457-10463. doi: 10.1158/0008-5472.CAN-05-1923
33. Gan, L. (2007). Therapeutic potential of sirtuin-activating compounds in Alzheimer’s disease. Drug News Perspect. 20, 233-239. doi: 10.1358/dnp.2007.20.4.1101162
34. Gibson, G. E., Haroutunian, V., Zhang, H., Park, L. C., Shi, Q., Lesser, M., et al. (2000). Mitochondrial damage in Alzheimer’s Disease varies with apolipoprotein E genotype. Ann. Neurol. 48, 1594-1601. doi: 10.1002/1531-8249(200009)48:3<297::AID-ANA3>3.0.CO;2-Z
35. Gong, H., Pang, J., Han, Y., Dai, Y., Dai, D., Cai, J., et al. (2014). Age-dependent tissue expression patterns of Sirt1 in senescence-accelerated mice. Mol. Med. Rep. 10, 3296-3302. doi: 10.3892/mmr.2014.2648
36. Grummt, I. (2003). Life on a planet of its own: regulation of RNA polymerase I transcription in the nucleolus. Genes Dev. 17, 1691-1702. doi: 10.1101/gad.1098503R
37. Haigis, M., Mostoslavsky, R., Haigis, K., Fahie, K., Christodoulou, D., Murphy, A., et al. (2006). SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic β cells. Cell 126, 941-954. doi: 10.1016/j.cell.2006.06.057
38. Hasahara, S., Chiba, S., Matsumoto, H., and Horio, Y (2005). Transcriptional regulation of neuronal genes and its effect on neural functions: NAD-dependent histone deacetylase SIRT1 (Sir2alpha). J. Pharmacol. Sci. 98, 200-204. doi: 10.1254/jphs.FMJ05001X2
39. Henderson, J., Swalwell, H., Boulton, S., Manning, P., McNeil, C., and Birch-Machin, M. (2009). Direct, real-time monitoring of superoxide generation in isolated mitochondria. Free Radic. Res. 43, 796-802. doi: 10.1080/10715760903062895
40. Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., et al. (2003). Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191-196. doi: 10.1038/nature01960
41. Ito, K. (2013). Frontiers of model animals for neuroscience: two prosperous aging model animals for promoting neuroscience research. Exp. Anim. 62, 275-280. doi: 10.1538/expanim.62.275
42. Jacquard, C., Trioulier, Y., Cosker, F., Escartin, C., Bizat, N., Hantraye, P., et al. (2006). Brain mitochondrial defects amplify intracellular [Ca2+] rise and neurodegeneration but not Ca2+ entry during NMDA receptor activation. FASEB J. 20, 1021-1023. doi: 10.1096/fj.05-5085fje
43. Koch, M., Ramsaransing, G., Arutjunyan, A., Stepanov, M., Teelken, A., Heersema, D., et al. (2006). Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis. J. Neurol. 253, 483-487. doi: 10.1007/s00415-005-0037-3
44. Koltai, E., Szabo, Z., Atalay, M., Bolodogh, I., Naito, H., Goto, S., et al. (2010). Exercise alters SIRT1, SIRT6, NAD and NAMPT levels in skeletal muscle of aged rats. Mech. Ageing Dev. 131, 21-28. doi: 10.1016/j.mad.2009.11.002
45. Lamming, D. W., Wood, J. G., and Sinclair, D. A. (2004). Small molecules that regulate lifespan: evidence for xenohormesis. Mol. Microbiol. 53, 1003-1009. doi: 10.1111/j.1365-2958.2004.04209.x
46. La Piana, G., Fransvea, E., Marzulli, D., and Lofrumento, N. (1998). Mitochondrial membrane potential supported by exogenous cytochrome c oxidation mimics the early stages of apoptosis. Biochem. Biophys. Res. Commun. 246, 556-561. doi: 10.1006/bbrc.1998.8664
47. Lee, J. M., Roche, J. R., Donaghy, D. J., Thrush, A., and Sathish, P. (2010). Validation of reference genes for quantitative RT-PCR studies of gene expression in perennial ryegrass (Lolium perenne L.). BMC Mol. Biol. 11:8. doi: 10.1186/1471-2199-11-8
48. Li, W., Zhang, B., Tang, J., Cao, Q., Wu, Y., Wu, C., et al. (2007). Sirtuin2, a mammalian homolog of yeast silent information regulator-2 longevity regulator, is an oligodendroglial protein that decelerates cell differentiation through deacetylating α-tubulin. J. Neurosci. 27, 2606-2616. doi: 10.1523/JNEUROSCI.4181-06.2007
49. Liszt, G., Ford, E., Kurtev, M., and Guarente, L. (2005). Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. J. Biol. Chem. 280, 21313-21320. doi: 10.1074/jbc.M413296200
50. Lombard, D., Alt, F., Cheng, H., Bunkenberg, J., Streeper, R., Mostoslavsky, R., et al. (2007). Mammalian Sir2 homolog SIT3 regulates global mitchondrial lysine acetylation. Mol. Cell. Biol. 27, 8807-8814. doi: 10.1128/MCB.01636-07
51. Longo, V. D., and Kennedy, B. K. (2006). Sirtuins in aging and age-related disease. Cell 126, 257-268. doi: 10.1016/j.cell.2006.07.002
52. Mansour, H., Chamberlain, C. G., Michael, I., Weible, W., Hughes, S., Chu, Y., et al. (2008). Aging-related changes in astrocytes in the rat retina: imbalance between cell proliferation and cell death reduces astrocyte availability. Aging Cell 7, 526-540. doi: 10.1111/j.1474-9726.2008.00402.x
53. Mawrin, C., Kirches, E., and Dietzmann, K. (2003). Single-cell analysis of mtDNA in amyotrophic lateral sclerosis: towards the characterization of individual neurons in neurodegenerative disorders. Pathol. Res. Pract. 199, 415-418. doi: 10.1078/0344-0338-00439
54. Menzies, F. M., Cookson, M. R., Taylor, R. W., Turnbull, D. M., Chrzanowska-Lightowlers, Z. M., Dong, L., et al. (2002a). Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis. Brain 125(Pt 7), 1522-1533. doi: 10.1093/brain/awf167
55. Menzies, F. M., Ince, P. G., and Shaw, P. J. (2002b). Mitochondrial involvement in amyotrophic lateral sclerosis. Neurochem. Int. 40, 543-551. doi: 10.1016/S0197-0186(01)00125-5
56. Michan, S., and Sinclair, D. (2007). Sirtuins in mammals: insights into their biological function. Biochem. J. 404, 1-13. doi: 10.1042/BJ20070140
57. Milne, J., and Denu, J. M. (2008). The Sirtuin family: therapeutic targets to treat diseases of aging. Curr. Pharm. Des. 12, 11-17. doi: 10.1016/j.cbpa.2008.01.019
58. Mostoslavsky, R., Chua, K., Lombard, D., Pang, W., Fischer, M., Gellon, L., et al. (2006). Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 124, 315-329. doi: 10.1016/j.cell.2005.11.044
59. Nakagawa, T., Lomb, D., Haigis, M., and Guarente, L. (2009). SIRT5 Deacetylatescarbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 137, 560-570. doi: 10.1016/j.cell.2009.02.026
60. Nasrin, N., Wu, X., Fortier, E., Feng, Y., Bare, O., Chen, S., et al. (2010). SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells. J. Biol. Chem. 285, 31995-32002. doi: 10.1074/jbc.M110.124164
61. North, B., Marshall, B., Borra, M., Denu, J., and Verdin, E. (2003). The human Sir2 ortholog, SIRT2, is an NAD+ dependent tubulin deacetylase. Mol. Cell 11, 437-444. doi: 10.1016/S1097-2765(03)00038-8
62. Oberley, L., and Oberley, T. (1988). Role of antioxidant enzymes in cell immortalisation and transformation. Mol. Cell. Biochem. 84, 147-153. doi: 10.1007/BF00421049
63. Okawara, M., Katsuki, H., Kurimoto, E., Shibata, H., Kume, T., and Akaike, A. (2007). Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults. Biochem. Pharmacol. 73, 550-560. doi: 10.1016/j.bcp.2006.11.003
64. Ozden, O., Park, S.-H., Kim, H.-S., Jiang, H., Coleman, M., Spitz, D., et al. (2011). Acetylation of MnSOD directes enzymatic activity responding to cellular nutrient status or oxidative stress. Aging 3, 102-107.
65. Pallas, M., Verdaguer, E., Tajes, M., Gutierrez-Cuesta, J., and Camins, A. (2008). Modulation of sirtuins: new targets for antiageing. Recent Patents CNS Drug Discov. 3, 61-69. doi: 10.2174/157488908783421492
66. Pandithage, R., Lilischkis, R., Harting, K., Wolf, A., Jedamzik, B., Luscher-Firzlaff, J., et al. (2008). The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility. J. Cell Biol. 180, 915-929. doi: 10.1083/jcb.200707126
67. Pillai, J. B., Isbatan, A., Imai, S. I., and Gupta, M. P. (2005). Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sirt2 deacetylase activity. J. Biol. Chem. 280, 43121-43130. doi: 10.1074/jbc.M506162200
68. Porcu, M., and Chiarugi, A. (2005). The emerging therapeutic potential of sirtuin-interacting drugs: from cell death to lifespan extension. Trends Pharmacol. Sci. 26, 94-103. doi: 10.1016/j.tips.2004.12.009
69. Qin, W., Yang, T., Ho, L., Zhao, Z., Wang, J., Chen, L., et al. (2006). Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J. Biol. Chem. 281, 21745-21754. doi: 10.1074/jbc.M602909200
70. Radak, Z., Atalay, M., Jakus, J., Boldogh, I., Davies, K., and Goto, S. (2009). Exercise improves import of 8-oxoguanine DNA glycosylase into the mitochondrial matrix of skeletal muscle and enhances the relative activity. Free Radic. Biol. Med. 46, 153-159. doi: 10.1016/j.freeradbiomed.2008.10.022
71. Ramadori, G., Lee, C., Bookout, A., Lee, S., Williams, K., Anderson, J., et al. (2008). Brain SIRT1: anatomical distribution and regulationn by energy availability. J. Neurosci. 28, 9989-9996. doi: 10.1523/JNEUROSCI.3257-08.2008
72. Raval, A. P., Dave, K. R., and Perez-Pinzon, M. A. (2006). Resveratrol mimics ischemic preconditioning in the brain. J. Cereb. Blood Flow Metab. 26, 1141-1147. doi: 10.1038/sj.jcbfm.9600262
73. Sauve, A. A., Wolberger, C., Schramm, V. L., and Boeke, J. D. (2006). The biochemistry of sirtuins. Annu. Rev. Biochem. 75, 435-465. doi: 10.1146/annurev.biochem.74.082803.133500
74. Schwer, B., Schumacher, B., Lombard, D., Cuiying, X., Kurtev, M., Gao, J., et al. (2010). Neural sirtuin 6 (Sirt6) ablation attenuates somatic growth and causes obesity. Proc. Natl. Acad. Sci. U.S.A. 107, 21790-21794. doi: 10.1073/pnas.1016306107
75. Schwer, B., and Verdin, E. (2008). Conserved metabolic regulatory functions of sirtuins. Cell Metab. 7, 104-112. doi: 10.1016/j.cmet.2007.11.006
76. Shi, T., Wang, F., Stieren, E., and Tong, Q. (2005). SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J. Biol. Chem. 280, 13560-13567. doi: 10.1074/jbc.M414670200
77. Sidorova-Darmos, E., Wither, R. G., Shulyakova, N., Fisher, C., Ratnam, M., Aarts, M., et al. (2014). Differential expression of sirtuin family members in the developing, adult, and aged rat brain. Front. Aging Neurosci. 6:333. doi: 10.3389/fnagi.2014.00333
78. Sinclair, D., and Guarente, L. (1997). Extrachromosomal rDNA circles—a cause of aging in yeast. Cell 91, 1033-1042. doi: 10.1016/S0092-8674(00)80493-6
79. Smith, B. C., and Denu, J. M. (2006). Sirtuins caught in the act. Structure 14, 1207-1208. doi: 10.1016/j.str.2006.07.004
80. Smith, J. (2002). Human Sir2 and the ‘silencing’ of p53 activity. Trends Cell Biol. 12, 404-406. doi: 10.1016/S0962-8924(02)02342-5
81. Spitz, D., and Oberley, L. (1989). An assay for superoxide dismutase activity in mammalian tissue homogenates. Anal. Biochem. 179, 8-18. doi: 10.1016/0003-2697(89)90192-9
82. Tang, B. L., and Chua, C. E. (2008). SIRT1 and neuronal diseases. Mol. Aspects Med. 29, 187-200. doi: 10.1016/j.mam.2007.02.001
83. Tao, R., Coleman, M., Pennington, J., Ozden, O., Park, S., Jiang, H., et al. (2010). Sirt3-mediated deacetylation of evolutionary conserved Lysine 122 regulates MnSOD activity in response to stress. Mol. Cell 40, 893-904. doi: 10.1016/j.molcel.2010.12.013
84. van der Horst, A., Tertoolen, L. G., de Vries-Smts, L. M., Frye, R. A., Medema, R. H., and Burgering, B. M. (2004). FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSIRT2 (SIRT1). J. Biol. Chem. 279, 28873-28879. doi: 10.1074/jbc.M401138200
85. Wang, F., Chan, C. H., Chen, K., Guan, X., Lin, H.-K., and Tong, Q. (2011). Deacetylation of FOXO3 by SIRT1 and SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation. Oncogene 31, 1546-1557. doi: 10.1038/onc.2011.347
86. Werner, H., Kuhlmann, K., Shen, S., Uecker, M., Schardt, A., Dimova, K., et al. (2007). Proteolipid protein is required for transport of sirtuin 2 into CNS myelin. J. Neurosci. 27, 7717-7730. doi: 10.1523/JNEUROSCI.1254-07.2007
87. Yamakuchi, M., Ferlito, M., and Lowenstein, C. (2008). miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl. Acad. Sci. U.S.A. 105, 13421-13426. doi: 10.1073/pnas.0801613105
88. Yang, T., and Sauve, A. A. (2005). NAD+ metabolism and sirtuins: metabolic regulation of protein deacetylation in stress and toxicity. AAPS J. 8, E632-E643. doi: 10.1208/aapsj080472